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ABSTRACT
Short interfering RNAs (siRNAs) target specific
mRNAs for their degradation mediated by RNA-
induced silencing complex (RISC). Persistent activa-
tion of siRNA-RISC frequently leads to non-targeting
toxicity. However, how cells mediate this stress
remains elusive. In this communication, we found
that the presence of non-targeting siRNA select-
ively induced the expression of an endoplasmic
reticulum (ER)-resident protein, non-selenocysteine
containing phospholipid hydroperoxide glutathione
peroxidase (NPGPx), but not other ER-stress
proteins including GRP78, Calnexin and XBP1.
Cells suffering from constant non-targeting siRNA
stress grew slower and prolonged G1 phase, while
NPGPx-depleted cells accumulated mature
non-targeting siRNA and underwent apoptosis.
Upon the stress, NPGPx covalently bound to
exoribonuclease XRN2, facilitating XRN2 to remove
accumulated non-targeting siRNA. These results
suggest that NPGPx serves as a novel responder
to non-targeting siRNA-induced stress in facilitating
XRN2 to release the non-targeting siRNA
accumulation.
INTRODUCTION
RNA induced post-transcriptional gene silencing (PTGS)
is one of the important regulation mechanisms in biologic-
al processes. PTGS, also known as RNA interference
(RNAi), was ﬁrst observed in plants and Caenorhabditis
elegans (1,2). In C. elegans, it was found that genes could
be silenced by sequence-speciﬁc double-stranded (ds)RNA
(3). The long dsRNA was processed into 22-nt short
interfering dsRNA (siRNA) (4), unwound (5) and then
loaded on its mRNA targets to promote their degradation
via antisense pairing (6). Gene silencing can be triggered
by exogenous dsRNAs and endogenous non-coding
hairpin-structured RNAs, such as microRNAs
(miRNAs). To date, over 700 miRNAs have been dis-
covered. miRNAs mediate gene silencing through retard-
ation of mRNA translation or, similar to siRNAs,
through degradation of mRNA (7). Both siRNAs and
miRNAs have been shown to be important in regulating
gene expression and participate in many biological
processes including development, differentiation, cell
growth and death.
RISC has a critical role in the process of gene silencing
(4–6). siRNA or miRNA associated with RISC to form a
siRISC complex and guides the complex to mRNA with
complementary sequences. Once siRISC binds to the
recognized mRNA, it activates RNase to cleave the
target. However, accumulation of siRISC by either
excess siRNAs or miRNAs may have deleterious effects
to cells such as undesired off-targeting gene silencing or
exhaustion of RISC. For example, excess siRNA against
ICAM-1 leads to TNFR-1 mRNA degradation (8).
Transfection of siRNAs against PPIB-1 resulted in
off-targeting silencing of 347 genes, a process that was
later identiﬁed to be dependent on the complementary of
merely 7nt between the siRNA and silenced genes (9).
Also, off-targeting siRNA can lead to exhaustion of
RISC that generates cellular stress and leads to cell
growth retardation (10). SiRNA stress must be released
to maintain normal cellular function. However, how cells
mediate siRNA stress remains unclear.
Serendipitously, we found that expression of NPGPx, an
endoplasmic reticulum (ER)-resident protein, was
upregulated in cells when non-targeting siRNAs were
introduced. These non-targeting siRNAs speciﬁcally
induced NPGPx expression, but not other canonical
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targeting siRNA stress grew slower, while cells deﬁcient of
NPGPx accumulated non-targeting siRNA and underwent
apoptosis. NPGPx bound to and colocalized with
exoribonuclease XRN2 and was essential for the nuclease
to remove the accumulated non-targeting siRNA. These
results provided, in part, a potential mechanism to
explain how cells resolve non-targeting siRNA stress.
MATERIAL AND METHODS
Lentivirus production and infection
pLKO-puro-shRNA vectors and empty vector
pLKO-AS1 (referred to shEmpty) were purchased from
National RNAi Core Facility (NRCF), Taiwan.
Lentivirus packaging was performed followed by the
manufacturer’s instruction. In brief, 293T cells were
grown to 80% conﬂuence and transfected with pMD.G,
pCMV-deltaR8.91 and pLKO-puro-shRNA using
Lipofetamin 2000 (Invitrogen). The culture medium con-
taining lentivirus was collected at 48 and 72h after trans-
fection. For infection, cells were grown to 70% conﬂuence
and infected with lentivirus (multiplicity of infection=1)
twice (6h each) in culture medium supplemented with
8mg/ml polybrene (Sigma H9268). Cells were selected
using 2mg/ml puromycin for 4 days.
RNAi transfection
Cells were transfected with indicated amount of RNAi
against human NPGPx (Stealth RNAi, clone
HSS142294, Invitrogen), mouse NPGPx, (Stealth RNAi,
MSS250292, MSS250294), mouse XRN2 (Stealth RNAi,
MSS280622), human PPIB-1 (Customized by Invitrogen.
Forward: 50-UUUgUAgCCAAAUCCUUUCUCUCCU-30;
reverse: 50-AggAgAgAAAggAUUUggCUACAAA-30)o r
control siRNA (Stealth RNAi, 12935-300, Invitrogen)
using Lipofectamin 2000TM (Invitrogen). The control
siRNA does not target to any gene in human, mouse or
rat by screening with the NCBI RefSeq as provided by the
manufacturer.
Plasmid construction
Human NPGPx was cloned in pLKO-AS2-Hygro vector
with NheI and AscI restriction enzymes. XRN2 expression
vector was received from Dr James Manley (Department
of Biological Science, Columbia University).
Western blot analysis
Cells were lysed with RIPA buffer [50mM Tris–HCl,
pH=7.4, 150mM NaCl, 2mM EDTA, 50mM NaF,
1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1%
SDS and 1mM phenylmethylsulfonyl ﬂuoride and 1mM
dithiothreitol (DTT)], and clariﬁed by centrifugation as
described (11). Cell lysate was denatured in SDS sample
buffer (50mM DTT, 1% SDS, 50mM Tris–HCl,
pH=6.8, 10% glycerol and 0.01% bromophenoblue),
boiled at 95 C for 10min and then subjected to sodium
dodecyl sulfate polyacrylamide gel electrophoresis
(SDS–PAGE) and western blot analysis. Primary
antibodies against NPGPx (GeneTex, GTX70266),
eIF2a (GeneTex, GTX25369), phosphorylated eIF2a
(GeneTex, GTX30727), GRP78 (BD, 610978), Calnexin
(Pierce, MA3-027), p53 (CalBiochem, OP-03), XNR2
(ab72181, Abcam) and a-tubulin (GeneTex, GTX11302)
were used according to the manufacturers’ instruction.
Immunoprecipitation assay
Cell lysates were collected from shLuc-transduced cells
using Lysis-250 and precleaned with protein A/G
agarose beads (11). NPGPx or XRN2 was precipitated
from the clariﬁed lysates with 1mg antibodies against
NPGPx (GTX108578, GeneTex) or XRN2 (ab72181,
Abcam) as previous described (11). The precipitated
protein complexes were separated by 8–16% gradient
SDS–PAGE followed by western blot analysis.
Northern blot analysis
Total RNA was extracted from mouse embryonic
ﬁbroblasts (MEFs) transduced with shLuc using Trizol
reagent (Invitrogen). Equal amount of total RNA from
WT or NPGPx
 /  MEFs (30mg/lane) were separated in
15% TBE-UREA acrylamide PAGE (Novex
TBE-UREA Gels, Invitrogen). RNAs were transferred
to Hybond
TM-N+ membrane (GE Healthcare),
cross-linked by UV irradiation and following the hybrid-
ization procedures as previously described (12).
Membranes were washed, and the siLuc signals were
detected by LightShift assay (Thermo).
RNA extraction, reverse transcription, and PCR and
quantitative real-time PCR analysis
Total RNA was extracted from cells using Trizol reagent
(Invitrogen) and converted into cDNA by reverse tran-
scription followed by the manufacture’s instruction
(ABI, 4368814). Speciﬁc cDNA amounts of following
genes were determined using Syber Green-based RT–
qPCR systems. Primers for human NPGPx (forward
50-GCAGGAGCAGGACTTCTACGACTTC-30 and
reverse 50-ACCGGTGACTGCAATCTTGCTAAAC-30),
human PPIB-1 (forward 50-CCTCTTCCGGCCTCAGC
TGTCCG-30 and reverse 50-CATGTTGCGTTCGGAG
AGGCGC-30) and human XBP-1 (forward 50-TTGCTG
AAGAGGAGGCGGAA3-0 and reverse 50-ACAGAGAA
AGGGAGGCTGGT-30) were used. House-keeping genes
such as S26 or b-actin served as internal controls (S26
primers: forward 50-CCGTGCCTCCAAGATGAC
AAAG-30 and reverse 50-ACTCAGCTCCTTACATGG
GCTT-30).
siRNA reverse transcription and qPCR analysis
Total RNA was extracted from cells for generating cDNA
fragments of shLuc and siLuc using NCodeTM miRNA
First-Strand cDNA Synthesis kit (MIRC-50) (Invitrogen).
The quantities of shLuc and siLuc RNA were measured
by quantitative real-time PCR (qPCR) using a primer
covered the stem–loop region of shLuc (primer for
shLuc, 50-CTCGCTCGAGCGAGGGCGAC-30) and
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for siLuc, 50-CCTAAGGTTAAGTCGCCCTCG-30), re-
spectively. U6 expression level was also determined for
serving as an internal control (primer for U6, 50-CGCA
AGGATGACCAGCAAATTC-30). qPCR was performed
using MIRC-50 kit followed by the manufacture’s instruc-
tion (Invitrogen).
Recombinant protein expression and puriﬁcation
pET-48b vector, which contains thioredoxin and His as a
tag (Novagen), was chosen for expressing NPGPx recom-
binant proteins to resolve the solubility issue in bacteria.
pET-48b-NPGPx was constructed by inserting an BamHI
and HindIII digested DNA fragment containing human
NPGPx with TEV protease cutting site at its N-terminus
into pET-48b. pET-48b-C2AS-NPGPx was generated by
PCR-directed mutagenesis method to change Cys57 and
Cys86 from the WT plasmid, pET-48b-NPGPx, into
alanine (GCC) and serine (TCC). pET-15b-hXRN2 was
constructed using pET-15b, which contains N-terminal
his-tag followed with a TEV cutting site, to express
XRN2 by ligand-independent cloning (LIC) method
(13). pET-48b-NPGPx and pET-48b-C2AS-NPGPx were
transformed into bacteria of BL21 (DE3), while
pET-15b-hXRN2 was transformed into BL21 star. These
his-tagged proteins were ﬁrst puriﬁed by nickel beads
(Sigma) and then digested with TEV protease to release
tags, which was removed by rebinding to nickel beads.
Finally, the desired proteins were further puriﬁed by gel
ﬁltration and the corresponding fractions were
concentrated using Amicon Ultra-10 (Millipore).
To perform the in vitro binding assay, the puriﬁed
NPGPx was treated with H2O2 ﬁrst and incubated with
nickel beads bound XRN2 for 20min. The beads were
then washed with 8M Urea and the bound proteins
were analyzed by western blot.
MEF preparation
The 13.5d NPGPx
+/+ and NPGPx
 /  embryos (manu-
script in preparation) were used for MEF preparation as
previously described (14). In brief, embryos were washed
with PBS, and chopped into small pieces in 1  trypsin.
Processed embryos were incubated with trypsin at 37 C
for 30min, then stopped the digestion with 10% fetal
bovine serum-containing low glucose dulbecco’s
modiﬁed eagle medium (DMEM). Cells were plated and
cultured following the 3T3 culture protocol in which 10
6
cells were passed into a 10-cm dish every 3 days.
Immunoﬂuorescence staining, Annexin V and cH2Ax
staining
MEFs were washed with PBS, pre-extracted with buffer
containing 80mM PIPES, pH 7.0, 100nM NaCl, 30%
glycerol, 0.5% Triton X-100 for 5min on ice and ﬁxed
with 4% paraformaldehyde [in phosphate buffer saline
with Tween 20 (PBST) with 0.3% Triton X-100] at room
temperature. The ﬁxed cells were incubated with primary
antibody against NPGPx (mouse polyclonal) and XRN2
(ab72181, Abcam) followed by corresponding secondary
antibodies conjugated with ﬂorescence (For
NPGPx: mouse IgG-FITC; XRN2: rabbit IgG-PE) and
then visualized by ﬂorescence microscopy. For apoptotic
cell detection, MEFs were costained with Annexin V
(Molecular Probes, A13201) and propidium iodide
(Sigma, P4170) and analyzed by FACS analysis. For
gH2Ax staining, MEFs transduced with shLuc or
control vector (shEmpty) were ﬁxed with 4%
paraformaldehyde, permeablized with 0.2% Tween-20
(in PBST), and subsequently stained with anti-gH2Ax
antibody (Novus, NB100-384). 40,6-diamidino-2-
phenylindole (DAPI) was used for DNA staining. The
stained cells were visualized by confocal microscopy.
Cell growth assay
Different passages of NPGPx
+/+ or NPGPx
 /  MEFs
transduced with viruses either containing shRNA or
NPGPx cDNA were seeded in 60mm culture dishes
(1 10
5 cells per dish) with puromycin-containing
low-glucose DMEM and incubated in humidiﬁed CO2 in-
cubator (37 C, 5% CO2). Medium was changed every 2
days and cell number was counted every 24h. For late
phase cell growth assay, MEFs were transduced with
shLuc at passage 1 and then kept in culture for another
4 passages. Cells were seeded in 60mm culture dishes at
passage 5 and cell numbers were counted every 24h,
respectively.
RESULTS
Non-targeting shRNA/siRNA induces NPGPx expression
In viral shRNA delivery systems, shRNA against
non-mammalian genes such as luciferase (shLuc), red
ﬂuorescent protein (shRFP) or LacZ (shLacZ) are
commonly employed as a control for most of the RNA
knockdown experiments. Using these control shRNAs, we
surprisingly found that NPGPx expression was increased
about 3-fold compared with the cells infected with the
virus carrying no shRNA (Figure 1a and b) and that
upregulation prolonged about a month in culture. To
conﬁrm NPGPx induction resulted from the expressed
non-targeting siRNA, we then used chemically synthesized
control siRNA, which did not match with any transcripts
of human, mouse or rat for transfection (Invitrogen).
NPGPx induction was observed in a dose-dependent
manner in cells transfected with increasing amount of
non-targeting siRNA (Figure 1c). Moreover, not only
the protein, the NPGPx mRNA was also upregulated in
the non-targeting shRNA expressing cells compared with
the control (Figure 1d). When transfecting with a known
off-targeting siRNA, PPIB-1 (9), the expression of
NPGPx was not increased (Figure 1e and f), suggesting
that the induction of NPGPx expression was not from
off-targeting siRNA. Thus, it is likely that the
upregulation of NPGPx may result from siRNA that
has no cognate target. To test this possibility, we ex-
pressed Luciferase mRNA in cells containing shLuc and
found that the NPGPx expression was diminished
(Figure 1g). Because NPGPx primarily resides in ER
(see below), we then tested whether ER stress response
could be triggered by the non-targeting shRNA/siRNA.
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ER stress proteins including GRP78, Calnexin, phos-
phorylated eIF2a and eIF2a (15) as well as spliced
XBP1 mRNA (15) was not altered (Figure 1i), suggesting
that non-targeting siRNA did not trigger the canonical
ER stress pathways. Thus, non-targeting shRNA/siRNA
may pose a unique stress that selectively upregulates
NPGPx expression.
Persistent expression of non-targeting shRNA/siRNA
retards cell growth with a prolonged G1 phase
It was reported that off-targeting shRNA/siRNA may
cause the exhaustion of RISC to generate cellular stress
resulted in growth retardation and cell death (10). To test
whether persistent expression of non-targeting shRNA
also inhibits cell growth, we compared the proliferation
proﬁles of a pair of MEFs with NPGPx proﬁciency or
deﬁciency (Figure 2a). Expression of non-targeting
shRNA in NPGPx-proﬁcient MEFs retarded their
growth, while no obvious inhibition was found in
NPGPx-deﬁcient MEFs (Figure 2b). Consistently, FACS
analysis of cell cycle proﬁles revealed that higher percent-
age of normal cells (MEFs and WI38 cells) with
non-targeting shRNA/siRNA prolonged G1 phase
compared with those without shRNA (Figure 2c and d).
These results suggest that expression of non-targeting
siRNA generates a stress, which retards cell growth and
prolongs G1 phase.
(a)( b)( c)
(f) (e) (d)
(i) (h) (g)
Figure 1. NPGPx expression was induced by non-targeting shRNA/RNAi. (a and b) Western blot analysis of NPGPx, p84 and a-tubulin proteins
from WI38 cells infected with lentivirus carrying shLuc, shRFP, shLacZ, GFP, shEmpty (shRNA cloning vector) or uninfected as control. Speciﬁc
antibodies against each protein were used as probes. p84 and a-tubulin served as internal loading controls. (c) Western blot analysis of NPGPx
protein level in WI38 cells transfected with various amount of non-targeting siRNA (CTRL siRNA). Relative NPGPx/p84 ratio was shown in below.
(d) NPGPx mRNA expression analyzed by RT–qPCR from WI38 cells infected with lentivirus carrying with shLuc, GFP or control vector
(shEmpty) or uninfected as control (mock). Relative NPGPx mRNA level (normalized with b-actin and compare with Mock) was shown. (e and
f) RT–qPCR analysis. WI38 cells transfected with non-targeting siRNA (Ctrl siRNA, 160nM) or PPIB-1 siRNA were used in this assay. The PPIB-1
mRNA amount (e) and NPGPx mRNA expression level (f) were shown. Mock: WI38 cells without siRNA transfection. (g) Western blot analysis of
WI38 cells infected with vector control (shEmpty) or shLuc, and then transfected with either pBSK or Luciferase expression vector (pGL3-Luc). Cell
lysates were harvested 48h after transfection for western blot analysis. Relative expression ratio of NPGPx/a-tubulin (Rel. NP/a-tu) was calculated.
(h) Expressions of stress-related proteins including NPGPx, Calnexin, GRP78, eIF2a, phospho-eIF2a (p-eIF2a) in WI38 cells infected with lentivirus
carrying shLuc, GFP, shRNA cloning vector (shEmpty) or uninfected as control (mock). a-Tubulin served as an internal loading control.
(i) Expression of unspliced (uXBP1) or spliced (sXBP1) XBP1 mRNA analyzed by RT–PCR from WI38 cells infected with lentivirus carrying
with shLuc, shRFP, shEmpty or uninfected as the control (mock). Cells treated with tunicamycin (2mg/ml for 8h) served as a positive control, where
spliced XBP1 (sXBP1) was detected. Ribosomal RNA S26 served as an internal loading control. Each experiment has been repeated at least twice,
and the representative data from one of these experiments were shown.
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NPGPx
 /  cells leads to ROS production,
genome damage and cell death
NPGPx
 /  MEFs appeared to be unresponsive transiently
to non-targeting siRNA-induced growth retardation
(Figure 2b). To investigate the consequence of the insensi-
tivity to this stress, we therefore compared the growth rate
between wild-type and NPGPx
 /  MEFs at late passage
(passage 5) under persistent non-targeting shRNA/siRNA
stress. Wild-type MEF grew slower at late passage, while
NPGPx
 /  cell numbers reduced steadily (Figure 3a).
Using annexin V staining assay, those cells were undergo-
ing apoptosis (Figure 3b). Moreover, ROS level was
highly elevated in non-targeting shRNA/siRNA stressed
NPGPx
 /  MEFs when compared with the unstressed
MEFs (Figure 3c). Consistently, the stressed NPGPx
 / 
MEFs had more gH2AX foci compared with the un-
stressed cells (Figure 3d and e). These results suggest
that there were more damaged DNA in non-targeting
siRNA stressed cells than unstressed cells. Thus, persistent
non-targeting shRNA/siRNA stress can lead to elevated
ROS, genome damage and apoptosis in NPGPx
 /  cells,
indicating the importance of NPGPx for cells to mediate
this stress.
(a)
(c)
(d)( e)
(b)
Figure 3. Persistent exposure to non-targeting siRNA stress led to
ROS production, DNA damage and apoptosis in NPGPx
 /  MEFs.
(a) Cell growth patterns of MEFs at passage 5. (b) Annexin V staining.
NPGPx
 /  MEFs at the fourth day from (a) were stained with Annexin
V and PI. Percentage of the apoptotic (Annexin V+PI ) cell was
illustrated. **P=0.005. (c) Endogenous ROS measurement.
NPGPx
 /  MEFs [same as in (b)] were stained with CM-H2DCFDA
(29) which converted into a green ﬂorescence when encounters intracel-
lular ROS, and analyzed by FACS. (d) A representative gH2Ax IF
staining with green ﬂorescence of NPGPx
 /  MEFs [same with (b)].
Blue: DAPI. (e). The percentage of gH2Ax positive staining cells from
(d). These experiments have been repeated three times.
(a)
(b)
(d)
(c)
Figure 2. Cells suffering from non-targeting siRNA stress grew slowly
with prolonged G1 phase. (a) Western blot analysis using MEFs (WT
or NPGPx
 /  MEFs) transduced with shLuc or control vector
(shEmpty). (b) Cell growth assay. MEFs (WT or NPGPx
 /  MEFs)
at early passages transduced with shLuc or control vector (shEmpty)
were seeded by equal amount (1 10
5 cell/dish) in 6cm dishes, and cell
numbers were counted every day. (c) Cell cycle analysis by FACS was
performed at 0, 16, 20 or 24h after cells were released from starvation.
The percentages of cells in G1, S or G2/M phase were shown individu-
ally by plot. (d) Cell cycle proﬁles of WI38 cells transduced with shLuc
or control vector (shEmpty). WI38 cells were synchronized with serum
starvation, and the cell cycle analysis was performed at 0, 16, 24, 44h
after cells released from starvation. The percentage of cells in G1 phase
was shown on each plot. These experiments have been repeated three
times with similar results.
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It is well documented that stress-induced proteins usually
are functional in releasing the stress. For example, GRP78
expression was induced by ER stress to release the ER
stress (15). As described above, NPGPx was induced by
siRNA stress, and therefore it is likely that NPGPx con-
tributes to eliminate non-targeting siRNA accumulation.
In order to measure mature siLuc RNA level, we ﬁrst re-
versely transcribed siRNAs as previously described (16)
and then used a primer (primer for siLuc, Figure 4a)
that recognized the sense strand of shLuc (i.e. siLuc) for
qPCR analysis. Since this primer sequence was also com-
plimentary to shLuc, siLuc and shLuc were all ampliﬁed
by using this set of primer in qPCR analysis. Therefore,
another primer targeting to the stem–loop region of shLuc
was designed to distinguish the precursor shLuc from
siLuc. When shLuc and siLuc RNA were measured by
qPCR, the shLuc RNA level was at least 200-fold lower
than siLuc (data not shown). Thus, the shRNA
contributed very little to the overall siRNA concentration.
Based on the observation, we measured the siLuc concen-
tration relative to U6 RNA of WT and NPGPx
 /  MEFs,
and found that NPGPx
   MEFs contained about 2-fold
higher siLuc than that of in WT cells (Figure 4b).
Similarly, using direct RNA blotting, NPGPx
 /  MEFs
also contained 2.5-folds higher siLuc RNA than WT cells
(a)( b)( c)( d)
(g) (f)
(e)
(h)( i)
Figure 4. NPGPx was required for releasing non-targeting siRNA stress. (a) Schematic of primers designed for siRNA detection. (b) Steady amount
of siLuc in MEFs transduced with shLuc. MEFs transduced with shLuc were used for measuring siLuc/U6 ratio by RT–qPCR at 4, 5, 7 days after
shLuc-lentivirus infection. siLuc RNA accumulation was observed in NPGPx
 /  MEFs. (c) Northern blot analysis of RNA from WT or NPGPx
 / 
MEFs transduced with shLuc probed with biotinylated-RNA against siLuc. tRNA was used as a loading control. The relative siLuc/tRNA ratio
(Rel. siLuc/tRNA) was shown. (d) Western blot analysis of NPGPx protein using NPGPx
 /  MEFs restored with WT or mutant NPGPx
(C2A2-NPGPx). a-Tubulin served as an internal control. Mock: MEFs without retroviral transduction. (e) Steady amount of siLuc in MEFs
transduced with shLuc. MEFs transduced with shLuc were used for measuring siLuc/U6 ratio by RT–qPCR as descrived in (b). siLuc accumulation
was found in C2A2-NPGPx restored MEFs compared with control MEFs (WT or WT-NPGPx restored MEFs). (f) NPGPx protein expression level
of MEFs transfected with 160nM control non-targeting siRNA (CTRL) or siNPGPx. (g) siLuc RNA level in NPGPx-depleted MEFs. WT MEFs
expressing shLuc were transfected with increasing amount of NPGPx siRNA. The ratios of cellular siLuc and U6 RNA were measured by RT–
qPCR. CTRL: MEFs cells transfected with 160nM non-targeting siRNA. (h and i) Stability of siLuc measured by RT–qPCR using DRB-treated
MEFs. Equal amount of reverse-transcribed RNA was used in the RT–qPCR analysis. Relative siLuc level (relative to 0h) was shown. The kinetic
plot indicated that the siLuc had a slower turnover rate in NPGPx
 /  MEFs (h) and C2A2-restored MEFs (i) when compared with control MEFs.
Each experiment has been repeated more than three times, and the representative data from one of these experiments were shown.
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for the difference, we generated NPGPx
 /  MEFs ex-
pressing either WT NPGPx or C2A2 mutant through
retroviral-mediated gene transfer (Figure 4d and e).
Since two cysteines, Cys57 and Cys86, were essential for
NPGPx biochemical activity, changing these two residues
into alanine as C2A2 mutant completely inactivated its
function (Wei et al., manuscript in preparation). By
comparing these two MEFs, we found that C2A2 express-
ing NPGPx
 /  cells contained about 2.5-folds siLuc
higher than that of in WT NPGPx-expressing cells
(Figure 4e), suggesting that active NPGPx was required
for reducing non-targeting siRNA. Similarly, depletion of
NPGPx by siRNA in human ﬁbroblast cells increased the
siLuc level (Figure 4f and Figure 4g). Next, to test whether
the high level of siLuc in NPGPx-deﬁcient cells may result
from slow turnover, we used 5,6-dichloro-1-b-D-
ribofuranosylbenzimidazole(DRB), which inhibits RNA
Pol II phosphorylation and blocks transcription (17), to
treat cells and measured the siLuc turnover kinetics
(Figure 4h and i). As shown in Figure 4h, siLuc was
degraded faster in WT MEFs compared with
NPGPx-deﬁcient cells. Consistently, the degradation rate
of siLuc in WT-expressing cells was faster than C2A2
mutant-expressing cells (Figure 4i). These results support
the notion that NPGPx is essential for reducing the accu-
mulation of non-targeting siRNA.
XRN2, an NPGPx-interacting exoribonuclease, plays a
role in releasing non-targeting siRNA
NPGPx does not have the required RNAse activity for the
removal of the accumulated non-targeting siRNA. It is
likely that NPGPx may modulate protein/enzymes for
this purpose. To search for such potential enzymes, we
incubated cell lysate with NPGPx-immobolized beads
and eluted the bound proteins by cleavage with TEV
protease for mass spectrometry (Wei et al., unpublished
data). One of those proteins, which covalently bound
to NPGPx, was the 50–30 exoribonuclease, XRN2, which
participates in siRNA/miRNA metabolism (18). To test
whether XRN2 plays a direct role in removing
non-targeting siRNA, we depleted XRN2 from WI38
ﬁbroblasts by two different shRNAs and found that the
cells accumulated the non-targeting siRNA (Figure 5a and
b). To test whether NPGPx and XRN2 are functional in
the same process, we compared the amount of the
accumulated non-targeting siLuc between wild-type and
NPGPx
 /  MEFs upon depletion of XRN2. In
wild-type MEF, non-target siRNA was increased upon
the depletion of XRN2, while in NPGPx
 /  MEFs,
which had a higher basal level, the accumulation of
non-targeting siRNA was not further increased
(Figure 5c and d). Consistently, NPGPx
 /  MEF express-
ing WT NPGPx accumulated high siLuc upon depletion
of XRN2 (Figure 5f, open bar), while cells expressing
C2A2 mutant the siLuc level was not affected by XRN2
silencing (Figure 5f, ﬁlled bar). Taken together, these
results suggest that NPGPx and XRN2 work together in
the same pathway in removing non-targeting siRNA.
NPGPx interacts with XRN2
To further demonstrate that these two proteins directly
work together, we then tested whether these two
proteins interact in vivo. As shown in Figure 6a,
(a)( c)( e)
(f) (d) (b)
Figure 5. NPGPx and XRN2 were associated for releasing non-targeting siRNA. (a) Western blot analysis of XRN2 protein expression in
shLuc-expressing WI38 cells infected with lentiviruses carrying with XRN2 shRNAs (two clones as indicated) or shEmpty as control. (b) RT–
qPCR analysis of relative siLuc expression level normalized to U6 in XRN2-depleted WI38 cells. (c and e) Western blot analysis of XRN2 from WT,
NPGPx
 /  MEFs (c) or NPGPx
 /  MEFs expressing WT or C2A2 mutant (e). MEFs were transfected with either 160nM non-targeting siRNA
(CTRL) or XRN2 siRNA (siXRN2), and analyzed XRN2 protein level by western blot. a-Tubulin serves as an internal control. (d and f) RT–qPCR
analysis of relative siLuc expression level in XRN2-depleted MEFs. siLuc RNA level was normalized with U6 RNA level. This experiment has been
repeated twice.
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XRN2. Reciprocally, NPGPx could be detected in the
immunoprecipitated XRN2 complex (Figure 6b). It was
noteworthy that NPGPx-XRN2 complex was held
through disulﬁde bond, because the immunoprecipitated
complex migrated in a much higher molecular weight
in SDS–PAGE without treatment with reducing agent
(Figure 6c). To further verify that the disulﬁde
bonding was critical for the interaction, we used
NPGPx
 /  cells expressing WT or C2A2-mutant for
co-immunoprecipitation experiment, and found that
XRN2 associated with WT but not C2A2 mutant
(Figure 6d). XRN2 is a nuclear protein (19). A small
portion of XRN2 apparently was translocated to cyto-
plasm when cells suffered from non-targeting siRNA
stress (Figure 6e). The cytosolic XRN2 appeared to be
colocalized with NPGPx in speciﬁc foci (Figure 6e).
Finally, to test whether these two proteins interact
directly, we performed in vitro binding assay using
puriﬁed proteins of WT NPGPx, C2AS-mutant and
(a)
(d)
(f)( g)
(e)
(b)( c)
Figure 6. NPGPx and XRN2 interacted through covalent bonding. (a and b) NPGPx was reciprocally coimmunoprecited with XRN2. Cell lysates
prepared from WI38 cells transduced with shLuc were used in this experiment. Asterisk: heavy chain; arrow: NPGPx. (c) NPGPx and XRN2 were
covalently associated. Immunocomplexes of NPGPx and XRN2 were analyzed by SDS–PAGE before adding or without reducing agent (+DTT or
 DTT). NPGPx and XRN2 were then blotted as indicated. (d) Coimmunoprecipitation analysis of XRN2 with WT NPGPx and C2A2 mutant in
shLuc-expressing MEFs. Cell lysates prepared from NPGPx  /  MEFs expressing WT or C2A2 mutant were used. Immunoprecipitated complexs
were separated by SDS–PAGE and probed by XRN2- or NPGPx-speciﬁc antibodies. (e) Immunoﬂuorescence staining of WI38 cells transduced with
shLuc or control vector (shEmpty). Green: NPGPx; red: XRN2; blue: DAPI. (f) NPGPx and XRN2 interacted directly in vitro. Puriﬁed XRN2
(rXRN2) were immobilized on nickel column, and incubated with puriﬁed NPGPx (oxidized form, oNPGPx) or C2AS mutant (C57AC86S). NPGPx
and XRN2 complex were eluted by imidazole and analyzed by western blot. These experiments have been repeated three times. (g) Model for NPGPx
responding to non-targeting siRNA stress. When cells experienced non-targeting siRNA stress, NPGPx expression was induced (1) and in turn
activated XRN2 (2) to release/reduce non-targeting siRNA (3). In contrast, cells without NPGPx will accumulate non-targeting siRNA stress (4) and
result in DNA damage, elevated ROS and apoptosis (5).
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bility than C2A2. His-XRN2 was ﬁrst immobilized on
nickel beads and then incubated with WT or C2AS
mutant separately. After washing with 8M Urea, the co-
valently bound NPGPx-XRN2 was eluted and detected by
western blot. As shown in Figure 6g, XRN2 directly
bound to WT NPGPx, but not C2AS mutant. These
data suggest that NPGPx and XRN2 interact through
covalent bonding when encountered with non-targeting
siRNA stress, and these covalent interaction required
Cys57 and Cys86 of NPGPx.
DISCUSSION
In this communication, we found that non-targeting
siRNA is a stress that induces NPGPx expression, which
co-operates with XRN2 to eliminate the accumulated
non-targeting siRNAs (Figure 6g). Under non-targeting
siRNA stress, NPGPx-proﬁcient cells exhibited a slower
growth rate with a slightly prolonged G1 phase, while
NPGPx-deﬁcient cells elevated endogenous ROS produc-
tion and underwent apoptosis. Non-targeting siRNA ap-
parently is a stress. Since control siRNAs are frequently
used in research laboratories and in clinical experiments,
the unintended consequence from the usage of
non-targeting siRNA may cause interference. Precaution
must be taken to avoid this side effect. One may use a low
dose of scramble siRNA instead of non-targeting siRNA
(for example, <20nM per experiment). Based on our
ﬁndings, we recommend that each control siRNA be
tested for causing the non-targeting siRNA effect by
screening NPGPx expression.
In addition to NPGPx, expressions of other genes
induced by non-targeting siRNA have been reported
(20) although their precise functions remain to be ad-
dressed. Translation of mRNA mainly takes place on
ER membrane. It was thought that the constitutively
activated siRISC due to overexpressing siRNA might
cause ER stress. However, neither ER chaperons
(GRP78 or Calnexin) nor ER-stress responding factors
(eIF2a and XBP-1) were affected upon non-target
siRNA (Figure 1, shEmpty). Similarly, NPGPx was not
induced by neither virus infection (Figure 1) nor
exogenouse viral RNA analog poly(dI:dC) transfection
(data not shown). These results suggest that non-targeting
siRNA expression causes a unique stress response that
does not involve the canonical ER-stress or viral
infection-induced signal pathway.
Cells suffering from non-targeting siRNA stress
retarded growth and prolonged G1 phase (Figure 2).
This phenotype can be explained as cells required time
to resolve the non-targeting siRNA stress before progress-
ing to S phase. Intriguingly, such observed phenotype
was not seen in early passaged NPGPx
 /  MEFs
(Figure 2). However, NPGPx
 /  MEFs with continuous
non-targeting siRNA stress resulted in the elevation of
ROS, DNA damage and cell death (Figure 3).
Accumulated non-targeting siRNAs in NPGPx
 /  cells
may impair the turnover of the available RISC and in
turn elevate ROS. Another possibility is that the
accumulated siRNA may ultimately be recognized as
foreign viral RNA and trigger antiviral responses as
reported of human T-cell leukemia virus type 1
(HTLV-1) (21) and hepatitis C virus (HCV) (22), and
activate interferon signal pathway (20) to antagonize
infection-like RNA stress. Thus, induction of NPGPx ex-
pression may be a self-preservation mechanism to protect
cells from damages caused by non-targeting siRNA.
Similar observation was also reported in p53-deﬁcient
cells, which were not arrested in G1 under ionizing radi-
ation (IR) (23), while p53
 /  mice developed cancer by the
age of 3-month (24). Thus, induction of NPGPx expres-
sion is critical for cells to resolve the non-targeting siRNA
stress.
It remains unclear how cells sense the non-targeting
siRNA stress to activate NPGPx. Since the non-targeting
siRNA stress is distinct from the current known ER stress
and interferon-induced stress response pathways, a novel
signal pathway that transmits the stress signal from the
accumulated siRISC complex to responders must exist.
Our preliminary data suggested that the NPGPx
promoter was transactivated by nucleolin (Wei et al.,
manuscript in preparation). It is likely that the stress
signal will pass this message to nucleolin and/or other
factors to activate NPGPx expression. Obviously,
elucidating this novel signal pathway will be both
challenging and interesting.
NPGPx belongs to the glutathione peroxidase (GPX)
family based on its primary sequence alignment;
however, it did not have glutathione peroxidase activity
(Lee et al., unpublished data). NPGPx may use its two
residues, Cys57 and Cys86, to activate other protein or
enzyme via disulﬁde shuttling. The yeast GPX-3 has
been shown to behave in a manner similar to NPGPx as
described above (25). Recently, a nuclear 50–30
exoribonuclease, XRN2, was identiﬁed to be responsible
for degrading a subset of miRNA in C. elegans (26). Its
homolog XRN1 was found to promote mature mir-382
and mir-378 decay in HEK293 cells (27). Consistent with
our observation described here, NPGPx bound to and
positively modulated XRN2 in releasing the accumulated
non-targeting siRNAs. Interestingly, when we aligned the
amino acid sequences of XRN2, we found that most of the
16 cysteine residues are conserved in yeast and human,
suggesting the importance of these cysteines for XRN2
function. Since XRN2 covalently bound to NPGPx
in vivo and in vitro (Figure 6), it is likely that NPGPx
may facilitate the disulﬁde bond formation of XRN2 to
activate its enzymatic activity. Consistent to this scenario,
C2A2 mutant was not able to cooperate with XRN2 in
responding to non-targeting siRNA stress. However, the
detailed biochemical mechanism of this activation
warrants further investigation.
It was reported that Ago2 carrying with sense strand
miRNA/siRNA, together with the targeting mRNA,
translocates from nucleus to cytosolic P-body (28). The
translocation of Ago2-miRNA-targeting mRNA was
aimed to degrade the mRNA there. Interestingly, we
observed that NPGPx and XRN2 also translocalized to
the distinct cytosolic foci under non-targeting siRNA
stress (Figure 6e). Thus, it is likely that non-targeting
Nucleic AcidsResearch, 2012, Vol.40,No. 1 331siRNA would go through a similar degradation pathway
along with Ago2 and XRN2 in P-body, because we also
observed that Ago2 and XRN2 were colocalized in the
cytosolic foci in our preliminary result. Nevertheless,
how NPGPx translocates to these distinct cytosolic foci
and what kind of post-translational modiﬁcation occurs
to NPGPx warrant further investigation.
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